CN113906028A - 稠合杂环衍生物 - Google Patents

稠合杂环衍生物 Download PDF

Info

Publication number
CN113906028A
CN113906028A CN202080039617.8A CN202080039617A CN113906028A CN 113906028 A CN113906028 A CN 113906028A CN 202080039617 A CN202080039617 A CN 202080039617A CN 113906028 A CN113906028 A CN 113906028A
Authority
CN
China
Prior art keywords
compound
group
alkyl
formula
hbv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080039617.8A
Other languages
English (en)
Chinese (zh)
Inventor
S·C·格罗瑟
L·G·德拉特
K·范戴克
P·J-M·B·拉布瓦松
S·M·A·彼得斯
B·R·R·凯斯特林
W·G·维斯丘伦
J·M·伯克
M·C·R·勒孔特
C·马丁内兹拉门卡
T·H·M·容克斯
邓刚
蒋益民
徐彦平
程战领
L·胡
S·D·库杜克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen R&D Ireland ULC
Original Assignee
Janssen R&D Ireland ULC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=71741889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN113906028(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen R&D Ireland ULC filed Critical Janssen R&D Ireland ULC
Publication of CN113906028A publication Critical patent/CN113906028A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN202080039617.8A 2019-05-28 2020-05-27 稠合杂环衍生物 Pending CN113906028A (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962853533P 2019-05-28 2019-05-28
EP19176933.0 2019-05-28
US62/853533 2019-05-28
EP19176933 2019-05-28
CN2020085720 2020-04-20
CNPCT/CN2020/085720 2020-04-20
PCT/US2020/034643 WO2020243135A1 (en) 2019-05-28 2020-05-27 Fused heterocyclic derivatives

Publications (1)

Publication Number Publication Date
CN113906028A true CN113906028A (zh) 2022-01-07

Family

ID=71741889

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080039617.8A Pending CN113906028A (zh) 2019-05-28 2020-05-27 稠合杂环衍生物

Country Status (19)

Country Link
EP (1) EP3976617B1 (https=)
JP (1) JP2022535734A (https=)
KR (1) KR20220012913A (https=)
CN (1) CN113906028A (https=)
AU (1) AU2020285718A1 (https=)
BR (1) BR112021022889A8 (https=)
CA (1) CA3138168A1 (https=)
CL (1) CL2021003155A1 (https=)
CO (1) CO2021016433A2 (https=)
CR (1) CR20210666A (https=)
DO (1) DOP2021000230A (https=)
IL (1) IL288322A (https=)
JO (1) JOP20210313A1 (https=)
MA (1) MA56043A (https=)
MX (1) MX2021014575A (https=)
PE (1) PE20220767A1 (https=)
PH (1) PH12021552974A1 (https=)
SG (1) SG11202113167QA (https=)
WO (1) WO2020243135A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024114709A1 (en) * 2022-12-01 2024-06-06 Janssen Sciences Ireland Unlimited Company A crystal form of a fused heterocycle derivative compound
WO2024140851A1 (zh) * 2022-12-28 2024-07-04 上海维申医药有限公司 一类Toll样受体抑制剂及其制备和应用

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022116999A1 (en) * 2020-12-02 2022-06-09 Janssen Sciences Ireland Unlimited Company Fused heterocyclic derivatives and their use in the treatment of hbv infection
AR124222A1 (es) * 2020-12-02 2023-03-01 Janssen Sciences Ireland Unlimited Co Derivados heterocíclicos condensados
WO2022116998A1 (en) * 2020-12-02 2022-06-09 Janssen Sciences Ireland Unlimited Company Fused heterocyclic derivatives as hbv inhibitors
US20240279227A1 (en) * 2021-06-02 2024-08-22 Janssen Sciences Ireland Unlimited Company Fused heterocyclic derivatives
AR126049A1 (es) 2021-06-02 2023-09-06 Janssen Sciences Ireland Unlimited Co Derivados heterocíclicos condensados

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107531691A (zh) * 2014-12-30 2018-01-02 诺维拉治疗公司 治疗乙型肝炎感染的衍生物和方法
WO2018005881A1 (en) * 2016-06-29 2018-01-04 Novira Therapeutics, Inc. Oxadiazepinone derivatives and their use in the treatment of hepatitis b infections
US20180186789A1 (en) * 2014-09-08 2018-07-05 Helmholtz Zentrum Muenchen - Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt (Gmbh Pyrazolopyridine derivatives and their use in therapy
CN109641896A (zh) * 2016-06-29 2019-04-16 诺维拉治疗公司 二氮杂酮衍生物及其在治疗乙型肝炎感染中的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021021564A2 (pt) * 2019-04-30 2022-01-04 Aicuris Gmbh & Co Kg Indol-2-carboxamidas inovadoras ativas contra o vírus da hepatite b (hbv)

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180186789A1 (en) * 2014-09-08 2018-07-05 Helmholtz Zentrum Muenchen - Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt (Gmbh Pyrazolopyridine derivatives and their use in therapy
CN107531691A (zh) * 2014-12-30 2018-01-02 诺维拉治疗公司 治疗乙型肝炎感染的衍生物和方法
WO2018005881A1 (en) * 2016-06-29 2018-01-04 Novira Therapeutics, Inc. Oxadiazepinone derivatives and their use in the treatment of hepatitis b infections
CN109641896A (zh) * 2016-06-29 2019-04-16 诺维拉治疗公司 二氮杂酮衍生物及其在治疗乙型肝炎感染中的用途

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024114709A1 (en) * 2022-12-01 2024-06-06 Janssen Sciences Ireland Unlimited Company A crystal form of a fused heterocycle derivative compound
WO2024140851A1 (zh) * 2022-12-28 2024-07-04 上海维申医药有限公司 一类Toll样受体抑制剂及其制备和应用

Also Published As

Publication number Publication date
DOP2021000230A (es) 2022-05-31
BR112021022889A2 (pt) 2022-01-04
MA56043A (fr) 2022-04-06
CL2021003155A1 (es) 2022-07-22
WO2020243135A1 (en) 2020-12-03
SG11202113167QA (en) 2021-12-30
CA3138168A1 (en) 2020-12-03
PH12021552974A1 (en) 2022-07-11
IL288322A (en) 2022-01-01
JP2022535734A (ja) 2022-08-10
KR20220012913A (ko) 2022-02-04
JOP20210313A1 (ar) 2021-11-25
BR112021022889A8 (pt) 2024-03-05
PE20220767A1 (es) 2022-05-16
MX2021014575A (es) 2022-05-24
CR20210666A (es) 2022-03-11
CO2021016433A2 (es) 2021-12-10
EP3976617B1 (en) 2025-04-23
EP3976617A1 (en) 2022-04-06
AU2020285718A1 (en) 2022-02-03

Similar Documents

Publication Publication Date Title
CN113906028A (zh) 稠合杂环衍生物
KR20180022818A (ko) 환화 술파모일아릴아미드 유도체 및 b형 간염 치료용 약제로서의 이의 용도
CN113710667A (zh) 用于治疗hbv感染或hbv诱发的疾病的稠合环嘧啶酮衍生物
CN113767101A (zh) 具有抗乙型肝炎病毒(hbv)活性的新的吲哚-2-甲酰胺类化合物
US20230076319A1 (en) Inhibitors of hepatitis b virus
CN117881661A (zh) 稠合杂环衍生物
US20220348592A1 (en) Fused heterocyclic derivatives
CN113906030A (zh) 稠合杂环衍生物
HK40066700A (zh) 稠合杂环衍生物
JP2022535208A (ja) 抗ウイルス剤としての縮合ヘテロ環誘導体
CN113906031A (zh) 作为衣壳组装调节剂的稠合杂环衍生物
CN114174300A (zh) 二氢嘧啶衍生物及其在治疗hbv感染或hbv诱发疾病中的用途
KR20220015420A (ko) 캡시드 조립 조절제로서의 디아제피논 유도체
EA047929B1 (ru) Сочлененные гетероциклические производные
CN117715909A (zh) 稠合杂环衍生物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40066700

Country of ref document: HK

AD01 Patent right deemed abandoned

Effective date of abandoning: 20251031

AD01 Patent right deemed abandoned